Inhibrx Net Invested Capital vs Net Receivables Analysis

INBX Stock

USD 14.56 0.37 2.48%

Inhibrx Biosciences, financial indicator trend analysis is infinitely more than just investigating Inhibrx Biosciences, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inhibrx Biosciences, is a good investment. Please check the relationship between Inhibrx Biosciences, Net Invested Capital and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx Biosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx Biosciences, guide.

Net Invested Capital vs Net Receivables

Net Invested Capital vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inhibrx Biosciences, Net Invested Capital account and Net Receivables. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Inhibrx Biosciences,'s Net Invested Capital and Net Receivables is -0.41. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Inhibrx Biosciences,, assuming nothing else is changed. The correlation between historical values of Inhibrx Biosciences,'s Net Invested Capital and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Inhibrx Biosciences, are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Net Invested Capital i.e., Inhibrx Biosciences,'s Net Invested Capital and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.41

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Net Receivables

Most indicators from Inhibrx Biosciences,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inhibrx Biosciences, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inhibrx Biosciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Inhibrx Stock please use our How to Invest in Inhibrx Biosciences, guide.At this time, Inhibrx Biosciences,'s Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to 2,133 in 2025, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	16.1M	31.8M	13.5M	18.3M
Depreciation And Amortization	1.2M	1.2M	2.3M	1.5M

Interest Expense Depreciation And Amortization

Inhibrx Biosciences, fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Capital Lease Obligations	Net Invested Capital
Total Assets		0.64	0.84	0.79	0.11	-0.15	-0.89	-0.38	-0.62	-0.71	1.0	0.18	0.47	1.0	-0.7	0.1	0.6	0.9	0.55	0.91	0.7	1.0	0.98	-0.13	-0.21	0.72
Short Long Term Debt Total	0.64		0.35	0.31	-0.48	-0.69	-0.3	0.42	-0.93	-0.68	0.66	-0.45	-0.17	0.66	-0.16	0.69	1.0	0.35	0.4	0.69	0.99	0.66	0.72	0.64	-0.7	0.21
Other Current Liab	0.84	0.35		0.99	0.41	0.35	-0.9	-0.61	-0.49	-0.28	0.81	0.58	0.72	0.81	-0.58	-0.2	0.3	0.9	0.72	0.81	0.45	0.82	0.78	-0.34	0.03	0.97
Total Current Liabilities	0.79	0.31	0.99		0.38	0.38	-0.85	-0.58	-0.48	-0.18	0.76	0.57	0.68	0.76	-0.49	-0.18	0.26	0.85	0.78	0.81	0.41	0.77	0.74	-0.32	-0.01	0.99
Total Stockholder Equity	0.11	-0.48	0.41	0.38		0.85	-0.56	-0.89	0.48	0.04	0.07	0.96	0.92	0.07	-0.63	-0.96	-0.51	0.53	-0.2	-0.17	-0.42	0.06	-0.07	-0.87	0.92	0.39
Property Plant And Equipment Net	-0.15	-0.69	0.35	0.38	0.85		-0.28	-0.77	0.52	0.53	-0.2	0.92	0.73	-0.2	-0.19	-0.87	-0.72	0.24	0.05	-0.23	-0.61	-0.19	-0.29	-0.77	0.77	0.45
Current Deferred Revenue	-0.89	-0.3	-0.9	-0.85	-0.56	-0.28		0.74	0.29	0.56	-0.87	-0.61	-0.82	-0.87	0.88	0.37	-0.25	-1.0	-0.37	-0.69	-0.38	-0.86	-0.79	0.52	-0.25	-0.79
Net Debt	-0.38	0.42	-0.61	-0.58	-0.89	-0.77	0.74		-0.39	0.05	-0.34	-0.91	-0.92	-0.34	0.72	0.86	0.47	-0.7	-0.06	-0.14	0.34	-0.34	-0.22	0.95	-0.75	-0.6
Retained Earnings	-0.62	-0.93	-0.49	-0.48	0.48	0.52	0.29	-0.39		0.41	-0.62	0.35	0.15	-0.62	-0.01	-0.7	-0.92	-0.33	-0.68	-0.79	-0.95	-0.64	-0.71	-0.65	0.77	-0.43
Accounts Payable	-0.71	-0.68	-0.28	-0.18	0.04	0.53	0.56	0.05	0.41		-0.74	0.17	-0.18	-0.74	0.72	-0.18	-0.67	-0.59	0.12	-0.47	-0.66	-0.72	-0.71	-0.07	0.13	-0.05
Cash	1.0	0.66	0.81	0.76	0.07	-0.2	-0.87	-0.34	-0.62	-0.74		0.14	0.43	1.0	-0.71	0.13	0.63	0.88	0.52	0.91	0.72	1.0	0.99	-0.1	-0.23	0.68
Non Current Assets Total	0.18	-0.45	0.58	0.57	0.96	0.92	-0.61	-0.91	0.35	0.17	0.14		0.94	0.14	-0.53	-0.89	-0.49	0.58	0.08	0.01	-0.36	0.14	0.02	-0.84	0.79	0.6
Non Currrent Assets Other	0.47	-0.17	0.72	0.68	0.92	0.73	-0.82	-0.92	0.15	-0.18	0.43	0.94		0.43	-0.78	-0.8	-0.22	0.8	0.1	0.22	-0.09	0.43	0.31	-0.79	0.71	0.66
Cash And Short Term Investments	1.0	0.66	0.81	0.76	0.07	-0.2	-0.87	-0.34	-0.62	-0.74	1.0	0.14	0.43		-0.71	0.13	0.63	0.88	0.52	0.91	0.72	1.0	0.99	-0.1	-0.23	0.68
Net Receivables	-0.7	-0.16	-0.58	-0.49	-0.63	-0.19	0.88	0.72	-0.01	0.72	-0.71	-0.53	-0.78	-0.71		0.5	-0.13	-0.87	0.11	-0.36	-0.2	-0.69	-0.59	0.61	-0.48	-0.41
Common Stock Shares Outstanding	0.1	0.69	-0.2	-0.18	-0.96	-0.87	0.37	0.86	-0.7	-0.18	0.13	-0.89	-0.8	0.13	0.5		0.72	-0.33	0.34	0.36	0.65	0.14	0.27	0.92	-0.98	-0.21
Non Current Liabilities Total	0.6	1.0	0.3	0.26	-0.51	-0.72	-0.25	0.47	-0.92	-0.67	0.63	-0.49	-0.22	0.63	-0.13	0.72		0.3	0.37	0.66	0.99	0.63	0.69	0.68	-0.71	0.16
Inventory	0.9	0.35	0.9	0.85	0.53	0.24	-1.0	-0.7	-0.33	-0.59	0.88	0.58	0.8	0.88	-0.87	-0.33	0.3		0.38	0.71	0.43	0.88	0.81	-0.48	0.22	0.79
Other Current Assets	0.55	0.4	0.72	0.78	-0.2	0.05	-0.37	-0.06	-0.68	0.12	0.52	0.08	0.1	0.52	0.11	0.34	0.37	0.38		0.81	0.48	0.55	0.59	0.17	-0.53	0.81
Other Stockholder Equity	0.91	0.69	0.81	0.81	-0.17	-0.23	-0.69	-0.14	-0.79	-0.47	0.91	0.01	0.22	0.91	-0.36	0.36	0.66	0.71	0.81		0.76	0.92	0.95	0.12	-0.51	0.77
Total Liab	0.7	0.99	0.45	0.41	-0.42	-0.61	-0.38	0.34	-0.95	-0.66	0.72	-0.36	-0.09	0.72	-0.2	0.65	0.99	0.43	0.48	0.76		0.72	0.78	0.58	-0.67	0.32
Total Current Assets	1.0	0.66	0.82	0.77	0.06	-0.19	-0.86	-0.34	-0.64	-0.72	1.0	0.14	0.43	1.0	-0.69	0.14	0.63	0.88	0.55	0.92	0.72		0.99	-0.1	-0.25	0.7
Short Term Debt	0.98	0.72	0.78	0.74	-0.07	-0.29	-0.79	-0.22	-0.71	-0.71	0.99	0.02	0.31	0.99	-0.59	0.27	0.69	0.81	0.59	0.95	0.78	0.99		0.02	-0.37	0.66
Common Stock	-0.13	0.64	-0.34	-0.32	-0.87	-0.77	0.52	0.95	-0.65	-0.07	-0.1	-0.84	-0.79	-0.1	0.61	0.92	0.68	-0.48	0.17	0.12	0.58	-0.1	0.02		-0.86	-0.35
Capital Lease Obligations	-0.21	-0.7	0.03	-0.01	0.92	0.77	-0.25	-0.75	0.77	0.13	-0.23	0.79	0.71	-0.23	-0.48	-0.98	-0.71	0.22	-0.53	-0.51	-0.67	-0.25	-0.37	-0.86		0.01
Net Invested Capital	0.72	0.21	0.97	0.99	0.39	0.45	-0.79	-0.6	-0.43	-0.05	0.68	0.6	0.66	0.68	-0.41	-0.21	0.16	0.79	0.81	0.77	0.32	0.7	0.66	-0.35	0.01

Click cells to compare fundamentals

Inhibrx Biosciences, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ISPY	ProShares SP 500
SPYI	SHP ETF Trust
QYLD	Global X NASDAQ

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx Biosciences,'s price analysis, check to measure Inhibrx Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences, is operating at the current time. Most of Inhibrx Biosciences,'s value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences,'s price. Additionally, you may evaluate how the addition of Inhibrx Biosciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Inhibrx Net Invested Capital vs Net Receivables Analysis

Net Invested Capital vs Net Receivables

Net Invested Capital vs Net Receivables Correlation Analysis

Correlation Coefficient

Net Invested Capital

Net Receivables

Inhibrx Biosciences, fundamental ratios Correlations

Inhibrx Biosciences, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Inhibrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Inventory	- 1.0	Current Deferred Revenue
Capital Lease Obligations	- 0.98	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.96	Total Stockholder Equity
Total Liab	- 0.95	Retained Earnings
Retained Earnings	- 0.93	Short Long Term Debt Total
Non Current Liabilities Total	- 0.92	Retained Earnings